ZGNX Share Price

Open 10.45 Change Price %
High 11.12 1 Day 0.35 3.33
Low 10.30 1 Week 0.40 3.83
Close 10.85 1 Month 2.35 27.65
Volume 423035 1 Year 0.92 9.26
52 Week High 13.70
52 Week Low 7.33
ZGNX Important Levels
Resistance 2 11.61
Resistance 1 11.30
Pivot 10.76
Support 1 10.40
Support 2 10.09
NASDAQ USA Most Active Stocks
CTRP 47.59 1.13%
ADBE 119.47 -0.13%
FSLR 33.57 -8.33%
FSLR 33.57 -8.33%
CERN 55.37 0.18%
BIDU 186.01 0.21%
AAPL 137.11 0.30%
AAPL 137.11 0.30%
FB 136.12 1.79%
MASI 87.05 2.03%
More..
NASDAQ USA Top Gainers Stocks
VALV 0.05 66.67%
LOCM 0.09 50.00%
BASI 1.33 31.68%
WRES 0.09 28.57%
INAP 2.31 27.62%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
AETI 2.40 23.08%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
LIWA 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

Zogenix, Inc. (NASDAQ: ZGNX)

ZGNX Technical Analysis 3
As on 22nd Feb 2017 ZGNX Share Price closed @ 10.85 and we RECOMMEND Buy for LONG-TERM with Stoploss of 9.95 & Buy for SHORT-TERM with Stoploss of 10.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
ZGNX Target for February
1st Target up-side 11.1
2nd Target up-side 13.24
3rd Target up-side 15.38
1st Target down-side 5
2nd Target down-side 2.86
3rd Target down-side 0.72
ZGNX Other Details
Segment EQ
Market Capital 232515696.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.zogenix.com
ZGNX Address
ZGNX
12400 High Bluff Drive
Suite 650
San Diego, CA 92130
United States
Phone: 858-259-1165
Fax: 858-259-1166
ZGNX Latest News
The Zogenix, Inc. (ZGNX) Research Coverage Started at Aegis   DailyQuint   - 23rd Feb 17
Zogenix Inc. (ZGNX) Moves Higher on Volume Spike for February 15   Equities.com   - 16th Feb 17
Zogenix, Inc. (ZGNX) stock coverage initiated with “Buy” in note to investors ...   The Ledger Gazette   - 14th Feb 17
Zogenix Inc. (ZGNX) Plunges 7.14% on February 10   Equities.com   - 11th Feb 17
Zogenix Inc. (ZGNX) Plunges 5.03% on January 23   Equities.com   - 24th Jan 17
Zogenix, Inc. Shares Galloped 15% Higher in February -- Here's Why   Motley Fool   - 11th Mar 16
Zogenix, Inc Gained 29% in 2015 -- Here's Why   Motley Fool   - 14th Jan 16
Why Zogenix, Inc. Shares Rocketed 22% Higher in May   Motley Fool   - 05th Jun 15
Zogenix Inc. Shares Crumbled in March -- Here's Why   Motley Fool   - 10th Apr 15
10.20   MarketWatch   - 31st Jan 11
Interactive Technical Analysis Chart Zogenix, Inc. ( ZGNX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Zogenix, Inc.
ZGNX Business Profile
Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company�s product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate, Zohydro (hydrocodone bitartrate, formerly ZX002) is a 12-hour extended-release formulation of hydrocodone without acetaminophen for the treatment of chronic pain requiring opioid therapy. It completed Phase 3 development of Zohydro in 2011. Sumavel DosePro and Zohydro are used for the treatment options available to patients and physicians in the United States. Its second DosePro investigational product candidate, Relday, is a injectable formulation of risperidone for the treatment of schizophrenia. In May, 2012, it submitted a New Drug Application to the Food and Drug Administration (FDA).